EASD 2019


At the European Society for the Study of Diabetes (EASD) Annual Meeting in Barcelona, Professor Bain discusses the major challenges in developing an oral GLP-1 receptor agonist and how was this overcome with semaglutide.



Professor Steve Bain introduced the session ‘The PIONEER journey: from concept to successful oral peptide delivery’ and provided an overview of the PIONEER clinical trial programme evaluating the use of oral semaglutide. Listen to the podcast to hear Professor Bain talk about the PIONEER programme. 

Click here to listen to the podcast.